FilingIndex
10-KThe Record

Keros Therapeutics, Inc. files 10-K

Filed Mar 9, 2022 · 4y ago · Accession 0001664710-22-000011

Plain English

Annual report — full-year financials, business overview, and risk factors.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
KROS
CIK
1664710
Form type
10-K
Filing date
Mar 9, 2022
Report date
Dec 31, 2021
Document
kros-20211231.htm
Size
52.3 MB